|
Market Closed -
Nasdaq
16:00:00 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 4.990 USD | -3.11% |
|
-6.38% | -43.42% |
| 08-24 | Vanda Pharmaceuticals' Skin Disease Drug Gets EU Orphan Drug Designation | MT |
| 08-10 | B. Riley Adjusts Vanda Pharmaceuticals Price Target to $12 From $17, Maintains Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.11% | -6.38% | -4.41% | -15.14% | -43.42% | +13.93% | +6.17% | -69.46% | -68.28% | 302M | |
| -1.38% | +0.20% | -1.61% | +57.66% | +72.85% | +46.42% | +96.33% | +10.54% | - | 69.18B | |
| -1.04% | -0.81% | +17.61% | +12.82% | +19.81% | +34.61% | +75.16% | +215.74% | +5,734.24% | 62B | |
| -4.29% | -3.98% | -3.09% | +23.05% | -31.10% | -16.22% | +350.66% | +333.86% | +752.92% | 26.19B | |
| +1.89% | +2.68% | +8.64% | +67.06% | +59.51% | +29.39% | +15.02% | -56.92% | - | 25.75B | |
| -2.20% | -2.00% | +3.87% | +6.49% | +1.57% | -1.22% | -14.48% | -72.78% | - | 24.29B | |
| +1.61% | -0.69% | +6.07% | +34.88% | +6.07% | +20.85% | -19.42% | -20.43% | +99.07% | 19.84B | |
| +1.26% | -14.23% | -19.67% | +40.41% | +184.40% | +170.04% | +298.75% | +1,445.16% | +733.35% | 15.65B | |
| -5.54% | +0.69% | +30.34% | +23.14% | -0.51% | -8.13% | +830.48% | +170.19% | +216.36% | 13.88B | |
| -0.43% | -4.28% | -11.89% | +8.23% | +17.39% | -9.90% | +454.70% | - | - | 14.09B | |
| +1.23% | -1.34% | +11.05% | +7.36% | +29.82% | +45.86% | +160.89% | +177.97% | +326.54% | 14.1B | |
| -3.11% | -2.04% | +3.09% | +4.70% | -10.15% | +22.95% | +197.49% | +559.18% | +5,091.07% | 12.09B | |
| -12.40% | -16.97% | -18.43% | -8.40% | +6.45% | +146.49% | +144.36% | +11.27% | +889.78% | 9.98B | |
| -4.67% | -4.47% | +0.33% | +7.27% | -19.65% | -30.53% | +138.01% | +122.00% | - | 11.18B | |
| +1.49% | +36.39% | +20.92% | +44.11% | +260.85% | +94.19% | +22.21% | -92.21% | - | 1.46B | |
| -4.33% | -8.02% | -6.50% | -2.90% | +9.08% | +40.19% | +102.48% | +105.67% | +690.31% | 9.64B | |
| -2.75% | -1.81% | +7.53% | +14.17% | +311.11% | +197.08% | +352.22% | -14.94% | - | 8.63B | |
| -0.55% | -1.91% | +1.96% | +19.47% | +28.33% | +91.00% | +14.48% | +123.86% | - | 8.81B | |
| -2.85% | -4.98% | -9.27% | +7.31% | +1.94% | -33.87% | +80.79% | -24.17% | - | 8.08B | |
| +0.17% | +0.18% | -12.24% | +8.82% | +177.63% | +512.87% | +554.32% | -47.95% | -53.12% | 8.02B | |
| Average | -1.98% | -2.00% | +1.22% | +18.03% | +54.10% | +68.30% | +193.03% | +151.40% | +1,310.20% | 18.16B | |
| Weighted average by Cap. | -1.61% | -1.89% | +3.22% | +26.56% | +41.97% | +47.91% | +164.37% | +160.96% | +2,467.18% |
- Stock Market
- Stocks
- VNDA Stock
- Sector Vanda Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
